Ceftriaxone Treatment for Community-Acquired Pneumonia

Treatment Duration and Dosing

For uncomplicated community-acquired pneumonia in children, the Infectious Diseases Society of America recommends treatment with ceftriaxone for 10 days with beta-lactam antibiotics 1, 2
The American Academy of Pediatrics and the Infectious Diseases Society of America suggest that for pneumococcal pneumonia, treatment should continue for at least 10 days when using beta-lactam antibiotics, as Streptococcus pneumoniae remains the most common bacterial pathogen at any age 1, 2
Therapeutic efficacy should be assessed after 2-3 days of treatment, and if no improvement is observed, clinical and radiological reassessment is required 1, 2
Apyrexia may be achieved in less than 24 hours for pneumococcal pneumonia, but 2-4 days may be necessary for other etiologies 2

The American College of Physicians recommends stopping antibiotics when the patient has been afebrile for at least 48 hours and meets all stability criteria, including heart rate ≤100 beats/min, respiratory rate ≤24 breaths/min, systolic blood pressure ≥90 mmHg, oxygen saturation ≥90% on room air, ability to maintain oral intake, and normal mental status 3
The Infectious Diseases Society of America advises against stopping therapy at the standard 7-10 day mark if complications develop, such as empyema, lung abscess, or persistent bacteremia, and recommends extending duration to 14-21 days in these cases 3

The American Thoracic Society recommends avoiding ceftriaxone monotherapy for severe pneumonia requiring ICU admission and suggests combination therapy with a macrolide 4